Balance Sheet

Current Liabilities	5.1m
Accounts Payable	1.7m
Accrued Liabilities	3.4m
Non-Current Liabilities	7.8m
Other Non-Current Liabilities	7.8m

Currency: USD

	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	7	4	2	3	51	7	12	29	61	44
Cash Equivalents	7	4	2	3	51	7	12	29	61	44
Short-Term Investments	0	0	14	35	8	19	8	0	0	0
Total Receivables	0	0	0	0	0	0	0	0	0	0
Accounts Receivables	0	0	0	0	0	0	0	0	0	0
Other Receivables	0	0	0	0	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0	6	0	0
Other Current Assets	0	0	0	0	1	1	2	2	1	1
Total Current Assets	7	4	17	38	60	26	22	37	62	45
PP&E Net	0	0	0	3	2	8	12	11	10	9
PP&E Gross	0	0	0	3	2	8	12	11	10	9
Accumulated Depreciation	0	0	0	0	1	1	2	2	3	3
Intangible Assets	8	7	7	6	5	5	4	3	3	2
Goodwill	3	3	3	3	3	3	3	3	3	3
Other Long-Term Assets	0	0	0	0	0	0	0	0	0	0
Other Assets	3	3	3	3	3	3	3	3	3	3
Total Assets	18 N/A	14 -20%	26 +84%	50 +89%	71 +42%	42 -41%	41 -2%	54 +31%	78 +44%	59 -24%
Liabilities
Accounts Payable	0	0	0	1	1	2	2	3	2	2
Accrued Liabilities	0	0	1	1	1	3	6	5	3	5
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	1	0
Other Current Liabilities	0	0	0	0	0	0	0	0	0	0
Total Current Liabilities	0	1	1	2	3	4	8	9	6	7
Long-Term Debt	0	0	0	0	0	0	0	0	65	0
Deferred Income Tax	2	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	2	1	7	11	10	9	8
Total Liabilities	2 N/A	1 -64%	1 +55%	4 +275%	4 +13%	11 +159%	18 +65%	19 +1%	80 +332%	15 -82%
Equity
Common Stock	0	0	0	0	0	0	0	0	0	0
Retained Earnings	0	3	13	38	76	123	173	236	295	337
Additional Paid In Capital	16	17	38	84	142	153	195	272	292	381
Other Equity	0	0	0	0	0	0	0	0	0	0
Total Equity	16 N/A	14 -15%	25 +85%	46 +82%	66 +44%	31 -54%	23 -26%	36 +56%	2 N/A	44 N/A
Total Liabilities & Equity	18 N/A	14 -20%	26 +84%	50 +89%	71 +42%	42 -41%	41 -2%	54 +31%	78 +44%	59 -24%
Shares Outstanding
Common Shares Outstanding	13	13	13	17	21	21	26	30	37	55

Pulse Biosciences Inc
NASDAQ:PLSE